Striatal D1 and D2 signaling differentially predict learning from positive and negative outcomes

[1]  Anne G E Collins,et al.  Opponent actor learning (OpAL): modeling interactive effects of striatal dopamine on reinforcement learning and choice incentive. , 2014, Psychological review.

[2]  P. Cowen,et al.  Tyrosine-free amino acid mixtures reduce physiologically-evoked release of dopamine in a selective and activity-dependent manner , 2014, Journal of psychopharmacology.

[3]  Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion , 2013, Psychopharmacology.

[4]  Michael J Frank,et al.  A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease. , 2012, Cell reports.

[5]  David J. Nutt,et al.  Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity , 2012, NeuroImage.

[6]  Anatol C. Kreitzer,et al.  Distinct roles for direct and indirect pathway striatal neurons in reinforcement , 2012, Nature Neuroscience.

[7]  P. Smittenaar,et al.  Decomposing effects of dopaminergic medication in Parkinson’s disease on probabilistic action selection – learning or performance? , 2012, The European journal of neuroscience.

[8]  K. Fuxe,et al.  Increased affinity of dopamine for D2‐like versus D1‐like receptors. Relevance for volume transmission in interpreting PET findings , 2012, Synapse.

[9]  J. Bargas,et al.  Dopaminergic modulation of striatal neurons, circuits, and assemblies , 2011, Neuroscience.

[10]  V. Voon,et al.  Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome , 2011, BMC neurology.

[11]  M. Frank,et al.  Dopaminergic Genes Predict Individual Differences in Susceptibility to Confirmation Bias , 2011, The Journal of Neuroscience.

[12]  M. Frank,et al.  From reinforcement learning models to psychiatric and neurological disorders , 2011, Nature Neuroscience.

[13]  Ethan S. Bromberg-Martin,et al.  Dopamine in Motivational Control: Rewarding, Aversive, and Alerting , 2010, Neuron.

[14]  Rune W. Berg,et al.  Influence of Phasic and Tonic Dopamine Release on Receptor Activation , 2010, The Journal of Neuroscience.

[15]  Murtaza Z Mogri,et al.  Cell Type–Specific Loss of BDNF Signaling Mimics Optogenetic Control of Cocaine Reward , 2010, Science.

[16]  A. Gjedde,et al.  Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking , 2010, Proceedings of the National Academy of Sciences.

[17]  M. Frank,et al.  Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms , 2009, Neuroscience.

[18]  D. Louis Collins,et al.  Motion correction of multi-frame PET data in neuroreceptor mapping: Simulation based validation , 2009, NeuroImage.

[19]  J. Woods,et al.  Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats , 2009, Behavioural pharmacology.

[20]  M. Frank,et al.  Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation. , 2009, Nature neuroscience.

[21]  C. Almli,et al.  Unbiased nonlinear average age-appropriate brain templates from birth to adulthood , 2009, NeuroImage.

[22]  M. Reuter,et al.  Dopamine DRD2 polymorphism alters reversal learning and associated neural activity , 2009, NeuroImage.

[23]  T. Robbins,et al.  Review Personality, Addiction, Dopamine: Insights from Parkinson's Disease Table 1. Possible Site of Striatal Dopamine Dysfunction Causing Different Motor and Cognitive Symptoms in Parkinson's Disease , 2022 .

[24]  Michael X. Cohen,et al.  A Role for Dopamine in Temporal Decision Making and Reward Maximization in Parkinsonism , 2008, The Journal of Neuroscience.

[25]  P. Greengard,et al.  Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity , 2008, Science.

[26]  Leonardo Fazio,et al.  Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory , 2007, Proceedings of the National Academy of Sciences.

[27]  Daniel Weintraub,et al.  Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease , 2007, Nature Clinical Practice Neurology.

[28]  Michael J. Frank,et al.  Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning , 2007, Proceedings of the National Academy of Sciences.

[29]  Michael J. Frank,et al.  Understanding decision-making deficits in neurological conditions: insights from models of natural action selection , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[30]  M. D’Esposito,et al.  Reversal learning in Parkinson's disease depends on medication status and outcome valence , 2006, Neuropsychologia.

[31]  R. Dolan,et al.  Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans , 2006, Nature.

[32]  Michael J. Frank,et al.  A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. , 2006, Behavioral neuroscience.

[33]  P. Glimcher,et al.  Midbrain Dopamine Neurons Encode a Quantitative Reward Prediction Error Signal , 2005, Neuron.

[34]  Michael J. Frank,et al.  Dynamic Dopamine Modulation in the Basal Ganglia: A Neurocomputational Account of Cognitive Deficits in Medicated and Nonmedicated Parkinsonism , 2005, Journal of Cognitive Neuroscience.

[35]  Michael J. Frank,et al.  By Carrot or by Stick: Cognitive Reinforcement Learning in Parkinsonism , 2004, Science.

[36]  C. Comtat,et al.  OSEM-3D reconstruction strategies for the ECAT HRRT , 2004, IEEE Symposium Conference Record Nuclear Science 2004..

[37]  Alain Dagher,et al.  Decreasing Amphetamine-Induced Dopamine Release by Acute Phenylalanine/Tyrosine Depletion: A PET/[11C]Raclopride Study in Healthy Men , 2004, Neuropsychopharmacology.

[38]  P. Cowen,et al.  Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: an [11C]raclopride PET study. , 2003, The American journal of psychiatry.

[39]  W. Schultz.  Getting Formal with Dopamine and Reward , 2002, Neuron.

[40]  John N. J. Reynolds,et al.  Dopamine-dependent plasticity of corticostriatal synapses , 2002, Neural Networks.

[41]  Sham M. Kakade,et al.  Opponent interactions between serotonin and dopamine , 2002, Neural Networks.

[42]  J. Wickens,et al.  A cellular mechanism of reward-related learning , 2001, Nature.

[43]  J. Bargas,et al.  D2 Dopamine Receptors in Striatal Medium Spiny Neurons Reduce L-Type Ca2+ Currents and Excitability via a Novel PLCβ1–IP3–Calcineurin-Signaling Cascade , 2000, The Journal of Neuroscience.

[44]  M. Zuckerman,et al.  Personality and risk-taking: common biosocial factors. , 2000, Journal of personality.

[45]  C. Benkelfat,et al.  Effects on Mood of Acute Phenylalanine/Tyrosine Depletion in Healthy Women , 2000, Neuropsychopharmacology.

[46]  Christer Halldin,et al.  A PET study of D1-like dopamine receptor ligand binding , 1999, Psychopharmacology.

[47]  Philip J. Cowen,et al.  Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release , 1999, Psychopharmacology.

[48]  R. Palmour,et al.  An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys , 1998, Psychopharmacology.

[49]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[50]  D. Louis Collins,et al.  Animal: Validation and Applications of Nonlinear Registration-Based Segmentation , 1997, Int. J. Pattern Recognit. Artif. Intell..

[51]  Marc Laruelle,et al.  Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans , 1997, Neuropsychopharmacology.

[52]  Peter Dayan,et al.  A Neural Substrate of Prediction and Reward , 1997, Science.

[53]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[54]  P. Dayan,et al.  A framework for mesencephalic dopamine systems based on predictive Hebbian learning , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  F. Thibaut,et al.  In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission , 1996, Neuropharmacology.

[56]  Karl J. Friston,et al.  A unified statistical approach for determining significant signals in images of cerebral activation , 1996, Human brain mapping.

[57]  D. Collins,et al.  Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.

[58]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[59]  M. Lorr,et al.  Evidence for bipolar mood states. , 1982, Journal of personality assessment.

[60]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .